Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lactoferrin and Probiotics for Fungal Infection Prevention in Preterm Neonates
NCT05283278Phase 1Completed
- Sponsor
- Ain Shams University
- Start
- Feb 2020
- Primary completion
- Mar 2021
- Modality
- Recombinant Proteins and Enzymes, Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 1, randomised trial of bovine lactoferrin, lactobacillus delbrueckii and limosilactobacillus fermentum in invasive fungal infection (IFI) (3 arms), sponsored by Ain Shams University. Primary endpoint: Number of participants with invasive fungal infection at 12 months. Started Feb 2020; status: completed.
02
Drugs
bovine lactoferrinlactobacillus delbrueckiilimosilactobacillus fermentum
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT05283278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05283278.